Monitoring of the healthy immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy.

Monitoring of the *healthy* immune response in the sentinel lymph node of patients undergoing a prophylactic mastectomy. - Immune responses in the sentinel lymph node.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36250

Enrollment

Registered

2011-07-04

Start date

2012-01-31

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastcancer mammacarcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women Age 18 yrs or older Undergoing prophylactic mastectomy Written informed consent

Exclusion criteria

Exclusion criteria: 1. Presence of invasive breast cancer or ductal carcinoma in situ upon pathological examination 2. Contralateral breastcancer 3. Any other form of cancer 4. Any surgery or (needle) biopsy of the breast or axilla in the last 3 months 5. Current immunosuppressive therapy (including chemotherapy) 6. Current immunotherapy 7. Autoimmune disorders

Design outcomes

Primary

Measure	Time frame
Establishing the healthy immune response in SLN of patients undergoing a prophylactic mastectomy.	—

Countries

Netherlands

Outcome results